MedPage Today) — LOS ANGELES — For surgeons already split on their preference of inhaled pulmonary vasodilator to prevent postoperative right ventricular (RV) failure, a shifting market is not helping decision-making, as highlighted by a debate…
1 Comment 1 Comment
Very important